Cellular Biomedicine Group (Cellular Biomedicine Group) Price-to-Operating-Cash-Flow : (As of May. 07, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Cellular Biomedicine Group Price-to-Operating-Cash-Flow?

As of today (2024-05-07), Cellular Biomedicine Group's share price is $19.75. Cellular Biomedicine Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was $-2.30. Hence, Cellular Biomedicine Group's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Cellular Biomedicine Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

CBMG's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.96
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Cellular Biomedicine Group's Cash Flow from Operations per share for the three months ended in Sep. 2020 was $-0.69. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 was $-2.30.

Cellular Biomedicine Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Cellular Biomedicine Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellular Biomedicine Group Price-to-Operating-Cash-Flow Chart

Cellular Biomedicine Group Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Cellular Biomedicine Group Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cellular Biomedicine Group's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Cellular Biomedicine Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellular Biomedicine Group's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellular Biomedicine Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cellular Biomedicine Group's Price-to-Operating-Cash-Flow falls into.

Cellular Biomedicine Group Price-to-Operating-Cash-Flow Calculation

Cellular Biomedicine Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	19.75	/	-2.296
	=

Cellular Biomedicine Group's Share Price of today is $19.75.
Cellular Biomedicine Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.30.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Cellular Biomedicine Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cellular Biomedicine Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellular Biomedicine Group (Cellular Biomedicine Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellular Biomedicine Group Inc (NAS:CBMG) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1345 Avenue of Americas, 15th Floor, New York, NY, USA, 10105

Website

http://www.cellbiomedgroup.com

Cellular Biomedicine Group Inc is a biotechnology company focused on the development of proprietary cell therapies for the treatment of cancer and degenerative diseases. The company has two major cell platforms: immune cell therapy for treating a broad range of cancers using cancer vaccines, Chimeric Antigen Receptor T-cell technologies, and anti-PD-1 technologies; and human-adipose-derived mesenchymal progenitor cells for treatment of joint and autoimmune diseases. The immuno-oncology and stem cell research team is based in both China and the United States.

Executives

Ag Novartis	10 percent owner	LICHTSTRASSE 35, BASEL V8 CH 4056
Pharma Ag Novartis	10 percent owner	LICHTSTRASSE 35, CH-4002, BASEL V8
Edward T Schafer	director	1400 31ST AVENUE SW, SUITE 60, MINOT ND 58701
Wen Tao Liu	director	530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Terry Belmont	director	530 UNIVERSITY DRIVE PALO ALTO CA 94301
Au Chun Kwok Alan	director	C/O CELLULAR BIOMEDICINE GROUP, INC. 530 UNIVERSITY AVENUE, #17 NEW YORK NY 94301
Hansheng Zhou	director	369 LUMO ROAD HONGSHAN DISTRICT WUHAN F4 430074
Gang Jacky Ji	director	XIXI RONGZHUANG 27-3 JINGCHANG ROAD, YUHANG DISTRICT, HANGZHOU, ZHEJIANG F4 311100
Viktor Pan	10 percent owner	HELI XI LU 183 NO. 531 SHANGHAI F4 201317
Srl Opea	director	VIA CESARE BATTISTA 1 MILAN L6 20122
Zheng Zhou	10 percent owner	FLAT B, 25/F, TOWER 6, MARINELLA 9 WELFARE ROAD, ABERDEEN HONG KONG K3 00000
Sailing Capital Overseas Investments Fund, Lp	10 percent owner	C/O UNIT 2006-08, 20F HARBOUR CENTRE 25 HARBOUR ROAD WAN CHAI K3 00000
Maplebrook Ltd	10 percent owner	P.O. BOX 31119 GRAND PAVILLION HIBISCUS WAY, 802 WEST BAY ROAD GRAND CAYMAN E9 KY1-1205
Tf Venture Capital Management Co., Ltd.	10 percent owner	PO BOX 472, 2ND FLOOR, HARBOUR PLACE 103 SOUTH CHURCH STREET, GEORGE TOWN GRAND CAYMAN E9 KY1-1106
Winsor Capital Ltd	10 percent owner	TRINITY CHAMBERS PO BOX 4301, ROAD TOWN TORTOLA D8 00000